TMJ: when insurers say no, reviewers often say yes

In 95 published external-review decisions involving tmj, independent physician reviewers overturned the insurer’s denial 54.7% of the time.

Published decisions
95
2001–2026
Overturned
54.7%
52 denials reversed

Most-fought treatments for tmj

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Jaw Surgery12
75%
MRI4
50%
SCP Consult Refer3
100%
Acupuncture3
33.3%

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
69
63.8%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
24
33.3%
Typical time to a decision
19 days
Most land between 8 and 21 days
Handled as urgent
25.3%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested reimbursement and prospective authorization and coverage for all or any of the temporomandibular joint (TMJ) specialist services including evaluation of new patient, craniofacial and maxillofacial procedure of the head, other musculoskeletal procedures of the head; and/or cast supplies and all or any of the office visits for orthotic device evaluation and adjustment. In this case, the patient had a diagnosis of TMJ arthralgia that is consistent with intra and extra-articular disorder of the TMJ complex. Extra-articular disorders can manifest as generalized tenderness of the masticatory and cervical musculature. The patient exhibited jaw clicking, jaw locking, limited mouth opening, neck pain, headaches, migraines, and morning head pain.
Medical Necessity · 2024 · IMR MN24-41288
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for Botox injections every 12 weeks.Botox is a neurotoxin that inhibits acetylcholine release at the neuromuscular junction, effectively reducing muscle hyperactivity. Botox has been used to treat patients with refractory bruxism and oromandibular dystonia who have failed to respond to adequate attempts at first-line therapies. A study demonstrated that Botox can significantly improve pain, jaw function, and muscle activity in patients with sleep bruxism and temporomandibular (TMJ) symptoms, with a strong safety profile. A randomized, placebo-controlled trial showed that Botox led to statistically significant improvements in sleep bruxism frequency and facial pain, with no serious adverse events.
Medical Necessity · 2025 · IMR MN25-44912

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for Botox injections. There is a lack of controlled studies, single or double-blind, that prove the efficacy of botulinum toxin used in the treatment of temporomandibular joint disorders. Temporomandibular joint disorders represent a complex and multifaceted set of conditions affecting the jaw joint and muscles controlling jaw movement. The treatment for temporomandibular joint disorders varies, ranging from conservative therapies to surgical interventions. Botulinum toxin, primarily known for its use in cosmetic procedures, has been explored as a treatment for temporomandibular joint disorders. The use of botulinum toxin in temporomandibular joint disorders is predicated on its ability to reduce muscle activity, thereby alleviating pain and dysfunction.
Experimental/Investigational · 2024 · IMR EI24-41724
Physician 1: The patient is a 35-year-old female with temporomandibular joint dysfunction and associated head and neck pain. Treatment with physical therapy produced significant improvement in symptoms. The submitted evidence does not demonstrate that she has been treated with a combination of dental occlusal splinting, analgesics and physical therapy. Orthotic splinting and occlusal equilibration has not been performed and the patient’s symptoms have recurred.A request has been made for authorization and coverage for an electromyography (EMG).
Experimental/Investigational · 2005 · IMR EI05-4254

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for tmj was denied, the published record says the denial is worth fighting.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for tmj? 54.7% won.

Explain my denial — freeStart my appeal · $39